Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Jun 2025 is 5.46% vs 58.42% in Jun 2024
Consolidate Net Profit
YoY Growth in quarter ended Jun 2025 is 8.55% vs 108.22% in Jun 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Jun 2025 is 17.39% vs 93.62% in Jun 2024
Interest
YoY Growth in quarter ended Jun 2025 is 2,025.00% vs -42.86% in Jun 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024
Compare Quarterly Results Of Aurisco Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is 4.08% vs 3.99% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 5.46% vs 58.42% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is -3.27% vs 68.17% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 8.55% vs 108.22% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is -6.18% vs 65.79% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 17.39% vs 93.62% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is 3.66% vs -14.58% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 2,025.00% vs -42.86% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has fallen from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






